FINANCE

Analysis: China’s Private Health Insurance Push Runs Into Obstacles

By Ding Feng, Wu Yujian and Jonathan Breen

Published: Apr. 22, 2026 4:32 p.m. GMT+8

00:00

00:00/00:00

Listen to this article 1x

China is seeking to elevate commercial health insurance into a stronger pillar of its health care system, but structural weaknesses continue to limit its role.

After nearly a decade of rapid growth, the sector’s premium income approached 1 trillion yuan ($140 billion) last year, still short of the 2 trillion yuan target set in 2020.

This year’s government work report mentioned commercial health insurance for the first time, placing it within the framework of a multitiered medical security system. Authorities and industry participants are discussing stronger support, including subsidies, tax incentives and closer coordination with the basic medical insurance (BMI) system.

You've accessed an article available only to subscribers

Subscribe today for just $.99.

VIEW OPTIONS

Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.

Subscribe to Save an extra $50. Introductory offer for new readers. Subscribe now.

Share this article

Open WeChat and scan the QR code

DIGEST HUB

Digest Hub

Back

Explore the story in 30 seconds

China's commercial health insurance premiums neared 1T yuan ($140B) last year, short of 2T target; govt report first mentions it, eyes subsidies/tax incentives.
Low payout ratios (30-40%) from high deductibles, commissions (35-40%), costs; data fragmentation limits underwriting/claims.
Innovative drug catalog launched but uneven; subsidies debated for fiscal/equity issues.

AI generated, for reference only